Search results
With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concerns
FierceBiotech· 2 days agoA week after an FDA committee declined to support an midomafetamine (MDMA) treatment for...
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
NPR· 2 days agoGeneral Hospital, who presented on behalf of Lykos about the need for more PTSD treatment. Gorman acknowledges the Lykos' therapy protocol is more “open-ended ...
MDMA, Juul and a cardiovascular disease study. 3 health stories you may have missed — and why they...
Yahoo Life Style via AOL· 7 days agoThe panel said there wasn't enough evidence that the treatment is effective and said the risks were...
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
Motley Fool via Yahoo Finance· 5 days agoThe second question was whether the intervention is worth the risk to patients; the vote was 10-1....
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
WLRN Miami· 2 days agoThe psychedelic drug MDMA is near the end of decades-long effort to enter mainstream medicine but...
Opinion | Was the FDA Panel Right to Recommend Against MDMA Approval?
MedPage Today· 4 days agoIn the past few years, there has been a resurgence in interest in psychedelic treatments -- for...
Moderna’s COVID, flu combination vaccine shows stronger immune response, company announces
WPXI· 5 days agoModerna is working on a single vaccine that it says will protect people against both COVID-19 and...
Unease as US drug agency weighs its use of independent scientists
Nature· 1 day agoAfter several controversial drug approvals, the US Food and Drug Administration is mulling changes...
Sleep deprivation disrupts memory: here’s why
Nature· 3 days agoStudy in rats shows that a key brain signal linked to memory formation deteriorates after broken sleep.
After FDA setback, psychedelic drugmakers distance themselves from a pioneer
Washington Post via Yahoo News· 5 days agoCORRECTION: A previous version of this article misstated the position of Rick Doblin, founder of the...